Peptide record

TPDB93296

P16 Blood-Brain Barrier modified_plain modified
6 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.

Standard-residue backbone model; source-recorded chemical modifications are not verified in these coordinates.

TPDB93296
P16
Blood-Brain Barrier
Delivery and barrier-penetrating peptides
B3Pred BBPpredict Peptipedia
modified_plain
Yes
A 6-aa modified blood-brain barrier peptide sequence curated from B3Pred, BBPpredict, and Peptipedia, with an available 3D structural model.
C-terminal: C-terminal amidation N-terminal: N-terminal acetylation
Sequence
VQILYK
Physicochemical Analysis

Sequence-only estimates are not provided for modified or non-standard source notation. Reported molecular properties, when available, are retained below with their source records.

Chemical Descriptors
6 reviewed residue count
C-terminal amidation Activity
Linear Activity
N-terminal acetylation Activity
Evidence Records 1 records
Evidence 1 Activity

Activity

Blood-Brain Barrier
These peptide-based modulators (Trojans) were non-amyloidogenic, stable in serum and showed minimal

Target

Human brain endothelial cells (EA.hy926)

Assay & Model

Field-emission transmission electron microscope
A3 peptide treated with this peptide, showed higher folds of decrease in fluorescence intensities a
Tauopathies
These peptides were capable of reducing the tau elicit toxicity by accelerating or impeding the self

Source & Reference

NA
B3Pdb

Other

Chemically synthesized
Trojan peptides are capable of translo- cating the BBB, without affecting its interity.
Translocation
Comined with A3 pepide